Kolon Investment

Kolon Investment is a venture capital and private equity firm headquartered in Seoul, South Korea, established in 2000. It engages in buyouts, mezzanine financing, corporate restructuring, growth capital, and turnaround investments. The firm targets a broad mix of sectors, including electronic components, petroleum and energy products, computers, and telecommunications equipment, and it also seeks opportunities in healthcare and technology. Kolon Investment concentrates its activity in South Korea, with a focus on Seoul, Gyeonggi, Incheon, and Gyeongbuk. It participates across the company life cycle, backing seed through growth-stage opportunities to support strategic development and value creation.

Sangjoon Ahn

CEO and President

Yang Seung-rak

Director

97 past transactions

Best Innovation

Seed Round in 2025
Best Innovation is a manufacturer specializing in cosmetic products. Its mission is to provide safe alternatives to potentially harmful skincare chemicals. The company produces products composed mainly of comfortable, organic ingredients, free from controversial substances, offering customers a healthier beauty option.

Boosterz

Venture Round in 2025
Boosterz is a company that specializes in growth marketing services aimed at enhancing direct-to-consumer (D2C) brands. It supports the five key elements of marketing throughout various stages, including product planning, launch, and growth. By providing marketing assistance after making equity investments in D2C brands, Boosterz creates opportunities for these companies to operate effectively as subsidiaries. This approach allows Boosterz to foster the development and success of partner brands by leveraging strategic marketing initiatives tailored to their specific needs.

Micro-one

Venture Round in 2025
Micro-One is an air functionality expert company that manufactures incinerators, ecological infrastructure, and advanced dust filters.

IEG

Venture Round in 2024
IEG develops and supplies hardware and software in the field of mechatronics, STEM, and electrical/electronics.

Dnotitia

Seed Round in 2024
Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large Language Models (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.

AIDIN ROBOTICS

Series B in 2024
AIDIN ROBOTICS is a developer of AI-driven sensors and robotic systems.

AGL

Series B in 2024
AGL is a golf technology company that focuses on connecting golf courses globally through its innovative SaaS-based AI platform. This platform facilitates real-time tee-time bookings, streamlining the reservation process for golfers and promoting digital transformation within the golf industry. AGL offers integrated solutions, including a Global Distribution System (GDS), payment processing, and enterprise resource planning (ERP), catering to both domestic and international golf courses. With partnerships established with over 1,000 golf courses across more than 30 countries, AGL aims to enhance the golfing experience and maximize revenue for clubs by providing user-friendly, cloud-based information technology solutions that minimize the need for face-to-face interactions and enable wireless payments.

AGL

Series B in 2024
AGL is a golf technology company that focuses on connecting golf courses globally through its innovative SaaS-based AI platform. This platform facilitates real-time tee-time bookings, streamlining the reservation process for golfers and promoting digital transformation within the golf industry. AGL offers integrated solutions, including a Global Distribution System (GDS), payment processing, and enterprise resource planning (ERP), catering to both domestic and international golf courses. With partnerships established with over 1,000 golf courses across more than 30 countries, AGL aims to enhance the golfing experience and maximize revenue for clubs by providing user-friendly, cloud-based information technology solutions that minimize the need for face-to-face interactions and enable wireless payments.

Creative MUT

Series A in 2024
Creative MUT is a media solutions company that specializes in content planning, production, BX, and VFX creations.

Mainline

Venture Round in 2024
Mainline is a technology company that specializes in developing cloud-based document management solutions using artificial intelligence. Its platform, which incorporates intelligent document processing (IDP) technologies such as machine learning, natural language processing, and optical character recognition, is designed to streamline and automate the processing of documents. More than 300 government agencies in South Korea currently utilize Mainline's system to enhance their document workflows. Recently, the company has introduced software that enables insurance companies to swiftly develop new products by simply modifying a single document, significantly reducing the time required for product development from several months to just one week. This innovative solution is also applicable to various organizations handling complex documents, including regulatory materials and contracts.

Hej home

Series B in 2024
Hej home is the largest smart home IoT brand in Korea under GoQual Co. Ltd. Hej Home is a company that aims to create a comfortable and transformed daily life that people may not have experienced before. It turns uncomfortable moments into enjoyable ones, making everyone's dream house a part of their everyday lives.

Go-Qual

Series B in 2024
Go-Qual (고퀄) is a Korean startup that provides home network systems and security alarm systems.

withwave

Venture Round in 2023
Withwave is a leading provider of high-speed connectivity solutions, specializing in the design and manufacture of B2B connectors and cables. The company excels in delivering exceptional speed and wide bandwidth, up to 56 Gbps or more, catering to four primary markets: Wireless Communications, Test & Instrumentation, Automated Test Equipment, and Network Systems. Withwave's portfolio spans RF, Microwave, and High-Speed Solutions, with expertise in Electromagnetic Field Analysis and Signal Processing. Their products serve diverse industries such as cellular phones and base stations, data networking, semiconductor and telecommunications equipment, and factory automation. The company prioritizes innovation and sustainability, continually expanding its technological capabilities to maintain a competitive edge and secure long-term success.

Neurophet

Series C in 2023
Neurophet, Inc., founded in 2016 and based in Seoul, South Korea, is a neuroscience company that specializes in developing advanced simulation software for brain stimulation effects. Their flagship product, Neurophet tES Lab, utilizes individual brain structure data and stimulus conditions to calculate and visualize these effects. The company's technology, known as Segengine, automatically segments brain magnetic resonance images into 107 regions within a minute, enhancing the precision of their neuro-navigation tools. These solutions are designed to assist clinicians in treating patients with brain diseases, including Alzheimer's, by providing detailed three-dimensional brain models and stimulation parameter guidance through deep learning and numerical optimization techniques.

EGNIS

Series B in 2023
EGNIS is a supplier of food products.

AB180

Series B in 2023
AB180 is a performance marketing firm that specializes in data-driven solutions to enhance business outcomes in the digital landscape. The company has developed a platform that leverages data analytics and marketing technology to help organizations gain insights into customer behavior. By collecting and processing real-time behavioral data from mobile users, AB180 enables businesses to better understand their customers and optimize their marketing strategies. This approach allows organizations to improve their marketing results and adapt effectively to the evolving digital market.

iCore

Series A in 2023
iCore is a manufacturer of machine vision solutions that specializes in providing imaging-based automatic inspection and analysis for various industries, including semiconductors, electronics, and automobiles. The company develops advanced machine vision components and vision modules, which include lenses, lighting, and semiconductors. By integrating these technologies, iCore aims to enhance quality control processes and boost productivity for its clients. The company's innovative approach to machine vision technology enables businesses to achieve greater efficiency and accuracy in their operations.

Daejin Advanced Materials

Series D in 2022
Daejin Advanced Materials Co. is a research institute that manufactures fullerene, electric, and thermally conductive polymer materials.

AIDIN ROBOTICS

Series A in 2022
AIDIN ROBOTICS is a developer of AI-driven sensors and robotic systems.

My Franchise

Series B in 2022
My Franchise is a company founded in 2019 in Seoul, South Korea, that focuses on bridging the gap between franchise headquarters and prospective founders. It has developed an online platform that serves as a resource for these two parties, facilitating a partnership that is mutually beneficial. The platform provides valuable startup information, such as the number of franchisees over the years, average sales figures, and the associated startup costs of domestic franchise brands. This allows prospective founders to effectively compare and analyze important brand information, categorized by industry, helping them make informed decisions in their franchise endeavors.

OurBox

Series B in 2022
OurBox is a logistics agency that specializes in providing comprehensive logistics solutions and fulfillment services tailored for online sellers. The company focuses on facilitating seamless product delivery for e-commerce businesses, offering end-to-end logistics-related services that help streamline operations. By catering to small businesses and individual sellers, OurBox enables its clients to concentrate on their core activities, such as product development and sales growth, while benefiting from cost savings and improved efficiency in their logistics processes.

Eleven Corporation

Series A in 2022
Eleven Corporation creates value for lifestyle and beauty products.

Ledger

Series A in 2022
Ledger is a mobile ledger app that provides sales, settlement, profit, and loss management services.

Innospace

Series B in 2022
Innospace Co Ltd is an aerospace and defense company that specializes in the development and provision of launch services for small satellites. The company focuses on creating hybrid rocket-powered small satellite launch vehicles, which are designed to deliver low-cost, low-latency, and eco-friendly launch solutions. By leveraging innovative technology, Innospace aims to establish a reliable presence in the small satellite market, offering services that meet the growing demands of satellite deployment while emphasizing sustainable practices.

Glorang

Series A in 2022
Glorang is a Korean Ed-Tech company that operates GGuge, a real-time online live class platform for K-12 students. It is a leading AI-enabled Ed-Tech provider with a global diagnostic solution and expansion into the APAC market, and it has claimed a dominant position in Korea’s assessment and psychology test market, capturing about 80% of that market. The platform connects veteran teachers with students to deliver live instruction and keeps learners informed about education trends to help them develop their talents and abilities, aiming to overcome limitations of traditional education through scalable, AI-enhanced assessments and access to experienced educators.

Kimcaddie

Series A in 2022
Kimcaddie is a company based in Seoul, South Korea, founded in 2019. It operates an online platform that serves as a comprehensive resource for golf enthusiasts, offering information about nearby golf stores. Users can find details on store locations, read reviews, and learn about available facilities. Additionally, Kimcaddie provides a screen golf platform, enhancing the overall golf experience by integrating various aspects of the sport. The company aims to connect golfers with relevant resources and improve access to golf-related services.

Uneedcomms

Series A in 2022
Uneedcomms, Inc. is a South Korean company established in 2014 that specializes in developing data-driven e-commerce, mobile, and marketing solutions. Its flagship products include SMARTSKIN, a mobile shopping application that enhances the user experience, and TARGETBOOK, an advanced advertising management tool that leverages big data to analyze consumer behavior in shopping malls. TARGETBOOK synchronizes product information in real time, allowing for dynamic advertising of items currently available in retail spaces. Additionally, it automates the creation and editing of marketing creatives, aimed at optimizing advertising efforts. Uneedcomms focuses on empowering small and medium-sized e-commerce businesses by automating repetitive tasks, enabling operators to concentrate on more strategic endeavors to succeed in the competitive digital marketplace.

Y-Biologics

Venture Round in 2022
Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a bispecific antibody platform technology known as AliCE, which maintains the structural integrity of the parental antibody, ensuring high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL, a unique library of human antibodies, which supports its research and development efforts. The company is recognized for its contributions to the global immuno-chemotherapeutic drug market and also offers contract research services, aiming to advance its position within the biotechnology sector.

Cellebrain

Series A in 2022
Cellebrain is a biotechnology company dedicated to developing stem cell-based gene therapies specifically targeting neurological disorders. The company employs a unique platform that focuses on a pipeline of therapeutic candidates utilizing mesenchymal stem cells as mediators for delivering therapeutic genes. This innovative approach aims to provide new treatment options for patients suffering from chronic stroke, addressing significant unmet medical needs in the field of neurology. Through its research and development efforts, Cellebrain seeks to advance the efficacy and accessibility of gene therapies for neurological conditions.

ePapyrus

Series A in 2022
ePapyrus is a company that specializes in software development services, focusing on document processing solutions. It offers a platform designed to provide a standardized electronic document format, leveraging advanced artificial intelligence technologies and expertise in PDF and document technology. ePapyrus delivers robust solutions that combine heuristics with stochastic methods to achieve precise semantic understanding of complex documents. This enables developers and businesses globally to maximize the potential of their digital documents, enhancing efficiency and usability.

ABLY

Series C in 2022
ABLY is a fashion platform and open e-commerce marketplace that enables sellers and influencers of various sizes to open online stores and offer products across fashion, beauty, lifestyle, and food. It operates a mobile app powered by a proprietary AI recommendation algorithm that personalizes product selections for each user, delivering curated shopping experiences.

Cyrus Therapeutics

Series B in 2022
Cyrus Therapeutics is a biotechnology company focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases with significant unmet medical needs. Incorporated in 2019 and based in Seoul, South Korea, the company specializes in discovering and developing molecular medicines for conditions related to metabolism, obesity, metastasis, and refractory issues. Utilizing a range of advanced drug modalities, including traditional small molecule inhibitors and targeted protein degraders, Cyrus Therapeutics is dedicated to developing treatment options for patients who are often considered undruggable.

Dataknows

Series A in 2022
Dataknows is an application that provides stock annuity, enterprise, investment, software, ICT, and data solutions.

Happy Moonday

Series A in 2021
Happy Moonday Inc. is a South Korean company founded in 2017 that specializes in manufacturing and selling organic sanitary products with a focus on women's health. The company offers a diverse range of items including organic cotton sanitary napkins, tampons, menstrual cups, underwear, feminine wash, and heating patches. Additionally, it provides menstrual cycle tracking applications to help women manage their health effectively. Happy Moonday aims to alleviate discomfort associated with menstruation, promoting a healthier lifestyle for women.

Cell Lab Med

Series B in 2021
Cell Lab Med is a drug research and development company.

Neurophet

Series B in 2021
Neurophet, Inc., founded in 2016 and based in Seoul, South Korea, is a neuroscience company that specializes in developing advanced simulation software for brain stimulation effects. Their flagship product, Neurophet tES Lab, utilizes individual brain structure data and stimulus conditions to calculate and visualize these effects. The company's technology, known as Segengine, automatically segments brain magnetic resonance images into 107 regions within a minute, enhancing the precision of their neuro-navigation tools. These solutions are designed to assist clinicians in treating patients with brain diseases, including Alzheimer's, by providing detailed three-dimensional brain models and stimulation parameter guidance through deep learning and numerical optimization techniques.

Balaan

Series B in 2021
Balaan operates an online marketplace for luxury fashion, offering multi-brand clothing, accessories, and jewelry from renowned brands. The platform emphasizes fast delivery, providing the latest luxury goods within three days and pursuing lower prices through contracts with European local boutiques.

Turing

Series A in 2021
Turing is a representative AI learning platform for math education.

Sellerhub

Series B in 2021
Imagine if you are the online seller, having to sign up and upload your products to 30+ different major commerce websites to maximize your sales. Sellerhub is a web-based commerce suite of solutions where you as the seller sign up, create your online shop, upload product information ONCE then it will be transferred/synched on up to 30+ different major commerce websites at the same time and allow you to manage all their orders in a single integrated dashboard. From building your online shop front, expanding commerce channels, as well as integrating marketing/ad and fulfillment operations, Sellerhub is a one-stop solution for online sellers to manage ALL of your commerce activities in a single dashboard. Key Benefits: 1. Create and manage a beautiful, fully customizable Flagship store online. 2. Single product upload, API-transfer up to 30+ major commerce websites and begin selling simultaneously 3. Fulfillment, Dropshipping, and professional services are also available for you to choose from the full suite of solutions, either directly or through partnership program Established in 2012 with accrued GMV of 1.2 Billion USD, Sellerhub offers a full suite of solutions & services that empower online seller's selling activities, helping you grow revenue and reduce cost/time managing.

BeyondBio

Venture Round in 2021
BeyondBio is a biotechnology company focused on researching and developing synthetic pharmaceutical drugs. Its primary objective is to create therapeutic agents for diseases currently lacking effective treatments, such as pancreatic cancer, Alzheimer's disease, and glioblastoma. By advancing innovative drug candidates and therapies, BeyondBio aims to enable medical practitioners to better protect patients from life-threatening conditions.

Neuromeka

Series D in 2021
Neuromeka is a robotics company specializing in the development of collaborative robots tailored for manufacturing environments. The company focuses on creating a robot-as-a-Service (RaaS) platform that facilitates the adoption of robotic automation for small and medium-sized enterprises. Neuromeka's robots are designed for safe interaction with human operators, ensuring user-friendly operation without the requirement for specialized expertise. By establishing a comprehensive ecosystem, Neuromeka aims to simplify the integration and management of robotic systems, making automation accessible and secure for various industries.

CMES Robotics

Series B in 2021
CMES Robotics is an AI-powered robotics company that enables 3D vision for factory robots. CMES AI vision software includes high-precision vision sensors, robot calibration, a processing core, a simulator, and robot control. It enables robots to pick up objects that are unstructured, flexible, or deformed, as well as load and unload them. CMES Vision software has been used in void-filling and random depalletization applications all over the world.

Go-Qual

Series A in 2021
Go-Qual (고퀄) is a Korean startup that provides home network systems and security alarm systems.

iPS Bio

Series A in 2021
iPS Bio is a biotechnology company focused on developing therapies for intractable and degenerative diseases using induced pluripotent stem cells. It operates a drug screening platform aimed at creating innovative drugs to address incurable conditions, particularly those affecting the nervous system. By harnessing the unique properties of stem cells, iPS Bio seeks to provide effective treatment options that enhance the quality of life for patients suffering from these challenging ailments. The company's commitment to advancing stem cell therapy positions it at the forefront of biopharmaceutical innovation.

Apitbio

Series A in 2021
APITBIO is a biotechnology company focused on the research and development of antibody therapeutics, particularly in the field of anti-cancer drugs. The company utilizes a comprehensive platform that encompasses various stages of drug development, including screening, discovery, optimization, and production of monoclonal and double antibodies. By advancing its research in antibody therapeutics, APITBIO aims to address significant unmet medical needs within the oncology sector, providing hospitals with innovative treatment options for cancer patients.

AffyXell Therapeutics

Series A in 2021
AffyXell Therapeutics is a biopharmaceutical company founded in January 2020 as a joint venture between Avacta and Daewoong. It focuses on developing mesenchymal stem cell–based cell and gene therapies for inflammatory and autoimmune conditions, as well as for preventing organ transplant rejection. The company’s pipeline aims to provide new therapeutic options for patients with diseases that currently lack effective treatments.

Autophagy Sciences

Series A in 2021
Autophagy Sciences is a biopharmaceutical company dedicated to developing novel treatments for intractable diseases through the mechanism of autophagy. The company focuses on drug discovery across various therapeutic areas, including non-alcoholic steatohepatitis, inflammatory bowel disease, macular degeneration, and degenerative brain disease. By leveraging autophagy control substances, Autophagy Sciences aims to provide innovative therapies that address conditions such as fatty liver and liver cancer, enhancing treatment options for patients facing these challenging health issues.

Blue Farm Korea

Series A in 2020
Blue Farm Korea supplies medical consumables, medical devices, and quasi-drugs for domestic and foreign pharmaceutical companies.

Poled

Series A in 2020
Poled is a manufacturer of car seats designed to enhance safety for infant passengers during car accidents. The company’s products are equipped with intelligent safety devices that proactively tighten the seat belt in response to sudden braking or sharp turns, thereby maintaining a secure environment for children. Poled's car seats have undergone rigorous real vehicle crash tests, ensuring that they meet high safety standards. By focusing on innovative safety features, Poled aims to provide parents with peace of mind while traveling with their children.

Agreable

Series B in 2020
Agreable is a brand commerce startup that manufactures and distributes lifestyle products.

Innospace

Series A in 2020
Innospace Co Ltd is an aerospace and defense company that specializes in the development and provision of launch services for small satellites. The company focuses on creating hybrid rocket-powered small satellite launch vehicles, which are designed to deliver low-cost, low-latency, and eco-friendly launch solutions. By leveraging innovative technology, Innospace aims to establish a reliable presence in the small satellite market, offering services that meet the growing demands of satellite deployment while emphasizing sustainable practices.

Kanaph Therapeutics

Series B in 2020
Kanaph Therapeutics is a biotechnology company focused on developing next-generation therapeutics for oncology and autoimmune diseases. Founded in 2019 and headquartered in Seoul, South Korea, the company engages in drug development activities ranging from discovery to early-stage clinical trials. Its therapeutic platform includes bi-specific antibodies, Fc-fusions, and small molecules. In oncology, Kanaph Therapeutics develops drugs with enhanced immuno-stimulatory activity in the tumor microenvironment for efficient tumor eradication. For autoimmune diseases, the company's pipeline features bispecific Fc-fusions that inhibit the alternative complement pathway, angiogenesis, and downstream complement activation. The company serves both Korea and the United States.

Cyrus Therapeutics

Series A in 2020
Cyrus Therapeutics is a biotechnology company focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases with significant unmet medical needs. Incorporated in 2019 and based in Seoul, South Korea, the company specializes in discovering and developing molecular medicines for conditions related to metabolism, obesity, metastasis, and refractory issues. Utilizing a range of advanced drug modalities, including traditional small molecule inhibitors and targeted protein degraders, Cyrus Therapeutics is dedicated to developing treatment options for patients who are often considered undruggable.

Kabrew

Series B in 2020
Kabrew is a craft brewing company that specializes in producing handcrafted beers. Committed to quality, the company utilizes high-standard ingredients to create a diverse range of alcoholic beverages. By focusing on creativity and craftsmanship, Kabrew aims to deliver unique flavors and an enjoyable experience for craft beer enthusiasts.

Select Star

Series A in 2020
Select Star is a data platform for AI technology that offers dataset building, storage, and analysis services.

Radiance

Series A in 2020
Radiance is a company that thinks of the healthy warmth of family.

ABLY

Series B in 2020
ABLY is a fashion platform and open e-commerce marketplace that enables sellers and influencers of various sizes to open online stores and offer products across fashion, beauty, lifestyle, and food. It operates a mobile app powered by a proprietary AI recommendation algorithm that personalizes product selections for each user, delivering curated shopping experiences.

Datumo

Series A in 2020
Datumo, formerly known as SelectStar Inc., specializes in a cloud-based artificial intelligence data production platform. The company has developed an application called Cash Mission, which collects and analyzes data while rewarding users for their contributions. By connecting corporate clients with a network of crowd-workers, Datumo aims to address the challenges of obtaining accurate data for AI applications. The platform not only facilitates this connection but also emphasizes the importance of quality and cost-efficiency in data production. Founded in 2018 and headquartered in South Korea, Datumo continues to innovate in the field of mobile crowd-sourcing to enhance data collection processes for enterprises.

CMES Robotics

Series A in 2020
CMES Robotics is an AI-powered robotics company that enables 3D vision for factory robots. CMES AI vision software includes high-precision vision sensors, robot calibration, a processing core, a simulator, and robot control. It enables robots to pick up objects that are unstructured, flexible, or deformed, as well as load and unload them. CMES Vision software has been used in void-filling and random depalletization applications all over the world.

THE PIRATES

Series B in 2020
The Pirates Co., Ltd. specializes in the development and operation of a mobile application that serves both wholesale and retail markets for seafood products. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an aquatic market news platform that delivers information on fresh seafood offerings. This platform connects consumers with suppliers, providing essential insights into the quality of marine products and facilitating informed purchasing decisions. Through its innovative approach, The Pirates aims to enhance the seafood purchasing experience by bridging the gap between consumers and the fish market.

April Bio

Series B in 2020
April Bio is a drug development company that develops antibodies and long-acting biologics.

TeamFresh

Series B in 2020
TeamFresh is a cargo and freight company that provides logistics services.

Spendit

Series A in 2020
Spendit is a B2B fintech company in Seoul, Korea.

AB180

Series A in 2020
AB180 is a performance marketing firm that specializes in data-driven solutions to enhance business outcomes in the digital landscape. The company has developed a platform that leverages data analytics and marketing technology to help organizations gain insights into customer behavior. By collecting and processing real-time behavioral data from mobile users, AB180 enables businesses to better understand their customers and optimize their marketing strategies. This approach allows organizations to improve their marketing results and adapt effectively to the evolving digital market.

KaiPharm

Series A in 2020
KaiPharm Co., Ltd. is a biotechnology company focused on drug discovery and development through the application of big data and artificial intelligence. The company has developed a unique virtual screening algorithm and a comprehensive solution for drug discovery, built upon an integrated database of compound structures and their relationships with various biological factors. A key initiative, known as KMAP, aims to generate extensive drug-induced transcriptome data using next-generation sequencing to facilitate drug repositioning. This project enhances the predictive accuracy of drug interactions by expanding analytical capabilities beyond existing public data limitations. Additionally, KaiPharm holds patents for two proprietary algorithms, BEAR and BACoN, which allow for drug virtual screening using bioactivity data without relying on structural information. These innovations are fueled by extensive internal research and machine learning methodologies, resulting in improved predictive accuracy in drug development efforts.

Amondz

Series A in 2020
Amondz is a jewelry ecommerce platform designed to transform the domestic jewelry market by facilitating connections between buyers and sellers. The company offers users quick access to a production list and provides price quotations, ensuring that consumers can make informed purchasing decisions. Additionally, Amondz emphasizes personalized customer service and consultation for sellers, enabling them to enhance their revenue streams. By creating a network of reliable sellers, Amondz aims to streamline the jewelry buying and selling process, ultimately benefiting both parties involved.

Balaan

Series B in 2019
Balaan operates an online marketplace for luxury fashion, offering multi-brand clothing, accessories, and jewelry from renowned brands. The platform emphasizes fast delivery, providing the latest luxury goods within three days and pursuing lower prices through contracts with European local boutiques.

Gint

Series A in 2019
GINT is a technology company focused on developing advanced systems for tractor and construction equipment manufacturers. Established by experts in automotive and information communication technology, GINT addresses the global demand for electronic control and unattended automation solutions. The company specializes in three core systems: Transmission and Hydraulic Control Units, Telematics, and Driverless Systems. These innovations are designed to assist manufacturers, particularly newer entrants in the market, in bridging the technological gap with established players. GINT’s technology enhances the efficiency of traditional transportation and production equipment, such as tractors and agricultural machinery, thereby providing added value and improving productivity for its clients. The company collaborates with prominent domestic firms, leveraging its expertise to advance the industry.

Neurophet

Series A in 2019
Neurophet, Inc., founded in 2016 and based in Seoul, South Korea, is a neuroscience company that specializes in developing advanced simulation software for brain stimulation effects. Their flagship product, Neurophet tES Lab, utilizes individual brain structure data and stimulus conditions to calculate and visualize these effects. The company's technology, known as Segengine, automatically segments brain magnetic resonance images into 107 regions within a minute, enhancing the precision of their neuro-navigation tools. These solutions are designed to assist clinicians in treating patients with brain diseases, including Alzheimer's, by providing detailed three-dimensional brain models and stimulation parameter guidance through deep learning and numerical optimization techniques.

Innospace

Seed Round in 2019
Innospace Co Ltd is an aerospace and defense company that specializes in the development and provision of launch services for small satellites. The company focuses on creating hybrid rocket-powered small satellite launch vehicles, which are designed to deliver low-cost, low-latency, and eco-friendly launch solutions. By leveraging innovative technology, Innospace aims to establish a reliable presence in the small satellite market, offering services that meet the growing demands of satellite deployment while emphasizing sustainable practices.

Kickgoing

Seed Round in 2019
Kickgoing is a developer of a kickboard-sharing platform designed for short-distance travel. The company provides a systematic management system that ensures the daily inspection of kickboards, enhancing their reliability and safety. Users can easily locate available kickboards through the company's mobile app, which also facilitates the locking and unlocking process via QR code scanning. This service aims to offer customers convenient and accessible transportation options for urban mobility, promoting an efficient way to navigate short distances.

CoHive

Series B in 2019
CoHive, formerly known as EV Hive, is Indonesia's largest co-working space provider, headquartered in Jakarta. The company offers a comprehensive ecosystem that includes co-working, co-living, co-retail, and event spaces, designed to foster community and support the growth of startups and small to medium enterprises (SMEs). With around 9,000 members across 33 locations in major cities such as Jakarta, Medan, Yogyakarta, and Bali, CoHive spans approximately 66,000 square meters of shared workspace. The majority of its members are startups and SMEs, while the remaining clientele includes enterprises from diverse industries. CoHive aims to be a pivotal community builder in Indonesia by connecting individuals and businesses, facilitating knowledge sharing, and providing flexible and affordable workspace solutions. The leadership team includes Co-founder and CEO Jason Lee, Co-founder and CCO Ethan Choi, COO Erich Hirawan, and CRO Iris Wee.

ABLY

Series A in 2019
ABLY is a fashion platform and open e-commerce marketplace that enables sellers and influencers of various sizes to open online stores and offer products across fashion, beauty, lifestyle, and food. It operates a mobile app powered by a proprietary AI recommendation algorithm that personalizes product selections for each user, delivering curated shopping experiences.

AB180

Venture Round in 2019
AB180 is a performance marketing firm that specializes in data-driven solutions to enhance business outcomes in the digital landscape. The company has developed a platform that leverages data analytics and marketing technology to help organizations gain insights into customer behavior. By collecting and processing real-time behavioral data from mobile users, AB180 enables businesses to better understand their customers and optimize their marketing strategies. This approach allows organizations to improve their marketing results and adapt effectively to the evolving digital market.

Future Medicine

Series B in 2019
Future Medicine Co., Ltd. is a South Korean drug development company founded in 2015 and located in Seongnam. It focuses on creating innovative treatments, specializing in anti-cancer, anti-inflammation, fibrosis, and anti-viral medications. The company utilizes its Nucleoside Library Platform to facilitate drug discovery across various therapeutic areas, including oral medications, diabetic nephropathy, autoimmune diseases, and viral infections such as the Zika virus. Future Medicine is committed to advancing healthcare through the development of multi-target anti-cancer therapies and cancer immunotherapy, aiming to address significant medical needs and improve patient outcomes.

M.MONSTAR

Series C in 2019
M.MONSTAR is a software development firm that specializes in e-commerce solutions for fashion shopping malls.

Millie

Series C in 2019
Millie is an online book reading application.

PR&D Company

Series B in 2019
PR&D Company designs and develops hey dealer app and website for car-selling services.

M.MONSTAR

Series B in 2018
M.MONSTAR is a software development firm that specializes in e-commerce solutions for fashion shopping malls.

Millie

Series B in 2018
Millie is an online book reading application.

Kickgoing

Seed Round in 2018
Kickgoing is a developer of a kickboard-sharing platform designed for short-distance travel. The company provides a systematic management system that ensures the daily inspection of kickboards, enhancing their reliability and safety. Users can easily locate available kickboards through the company's mobile app, which also facilitates the locking and unlocking process via QR code scanning. This service aims to offer customers convenient and accessible transportation options for urban mobility, promoting an efficient way to navigate short distances.

ProtoPie

Series A in 2018
ProtoPie is a software company that specializes in interactive prototyping tools, enabling designers and engineers to create sophisticated prototypes without the need for coding. Its platform allows users to transform UI and UX design concepts into highly interactive prototypes for mobile, desktop, web, and IoT applications. Recognized for its ease of use and powerful capabilities, ProtoPie is adopted by leading global brands such as Google, Microsoft, R/GA, and Ideo. The company focuses on helping designers ideate, iterate, and innovate effectively, addressing contemporary design challenges in a user-friendly manner.

Future Medicine

Series A in 2018
Future Medicine Co., Ltd. is a South Korean drug development company founded in 2015 and located in Seongnam. It focuses on creating innovative treatments, specializing in anti-cancer, anti-inflammation, fibrosis, and anti-viral medications. The company utilizes its Nucleoside Library Platform to facilitate drug discovery across various therapeutic areas, including oral medications, diabetic nephropathy, autoimmune diseases, and viral infections such as the Zika virus. Future Medicine is committed to advancing healthcare through the development of multi-target anti-cancer therapies and cancer immunotherapy, aiming to address significant medical needs and improve patient outcomes.

Korea Credit Data

Series A in 2018
Korea Credit Data Co., Ltd. is a Seoul-based company that specializes in developing business management software, particularly for small and medium enterprises. Founded in 2016, its flagship product, CashNote, enables users to manage card payment schedules, conduct customer analysis, and perform tax invoice inquiries. In addition to CashNote, Korea Credit Data offers a range of services that include customer analysis, point-of-sale (POS) systems, and payment solutions through its various subsidiaries. The company serves over two million businesses in Korea, aiming to address challenges faced by business owners throughout their operational lifecycle. By forming strategic partnerships with leading industry players, Korea Credit Data has established a strong market presence and expanded its offerings to include payment networks and credit bureau services, enhancing its ability to support its clients effectively.

J2H Biotech

Series B in 2018
J2H Biotech is a bio-venture company dedicated to the development of small-molecule drugs aimed at treating rare and intractable diseases. The company specializes in creating synthetic medications that enhance oral absorption rates and employs patented systems to facilitate the availability of generic drugs for conditions such as rare diseases, infectious diseases, and liver diseases. By focusing on these innovative approaches, J2H Biotech seeks to provide healthcare professionals with differentiated therapeutic options that can improve patient outcomes and contribute to overall public health.

Wantedlab

Series B in 2017
Wantedlab, Inc. operates a crowd recruiting platform that enables users to refer job applicants to companies and earn rewards when those applicants are hired. Founded in 2015 and headquartered in Seoul, South Korea, the platform has attracted over 5,000 companies and hundreds of thousands of users. Notable clients include IBM, Facebook, Microsoft, eBay, WeWork, Rakuten, and Tencent, all of which utilize Wanted to identify and recruit top talent in Asia. Since its inception, Wantedlab has raised over $20 million in funding and is actively expanding its presence to major cities worldwide.

Dunamu

Series C in 2017
Dunamu Inc. is a South Korean company founded in 2012 that specializes in blockchain and securities services. It operates UPbit, a prominent global cryptocurrency exchange, as well as Stockplus, a securities information and trading platform, and U-Stockplus, an over-the-counter platform for private company trading. Additionally, Dunamu offers Luniverse, a blockchain-as-a-service solution, and Onboard, an equity management platform designed for private companies to manage shareholder equity electronically. The company's services are accessible through a mobile application, which provides users with real-time cryptocurrency prices and analytics, ensuring a secure and user-friendly trading experience across various markets.

Andar

Venture Round in 2017
Andar Co., Ltd., established in 2015 and headquartered in Paju, South Korea, operates a multi-channel retail business focused on fashion and lifestyle products. The company specializes in designing, manufacturing, and selling athletic and gym wear for women and children, catering to both online and offline markets through its e-commerce platform and physical stores.

Eutilex

Series A in 2016
Eutilex Co., Ltd. is a South Korean biotechnology company specializing in the development of innovative immunotherapy technologies. The firm focuses on anti-tumor treatments, specifically anti-tumor T cell therapy and antibody therapeutics. Its product pipeline includes notable therapies such as T Cell Therapy (4-1BB CTL) and CAR-T, which are designed to enhance the body's immune response against cancer. Eutilex markets its therapeutic innovations throughout South Korea, aiming to advance cancer treatment through its cutting-edge approaches in immunotherapy.

Albam

Series A in 2016
Albam : A mobile based HR Solution that is available for both Managers(Admins) and Staffs in App both IOS & Android. The average HR manager spends 45 minutes a day to calculate time attendance & payroll. With Albam, time is reduced by 70% to only 15 minutes. Albam help enterprises in simplifying and automating their time attendance system to payroll solution. Our easy to use and simple Cloud based Human Resource solution helps companies in reducing the high costs that are often associated in the investment of Time Attendance system which includes the purchase of expensive fingerprint machines and training of IT Personnels. With Albam, employees can clock in and clock out directly right away from their smartphone, clock in and clock out has never been this easier with Albam.

Newploy

Series A in 2016
Newploy is a South Korean company founded in 2014 that specializes in developing a payroll work automation platform. Based in Seoul, the company leverages robotic process automation (RPA) technology to streamline payroll tasks, including salary calculation, transfer, reporting, and payment. Newploy's software offers comprehensive workforce management solutions, allowing businesses to efficiently track employee work hours, manage leave, monitor attendance, and handle work schedules. By centralizing these functions, Newploy enables organizations to optimize their staffing needs and enhance operational efficiency.

White Life Science

Series B in 2016
White Life Science is a pharmaceutical drug development company focused on improving human health through the creation and production of a range of medicines. The company specializes in developing digestive, prescription, and over-the-counter drugs, offering a diverse portfolio that caters to various medical needs. In addition to its pharmaceutical offerings, White Life Science provides medication information to ensure that patients have access to essential knowledge about their treatments, ultimately enhancing the overall healthcare experience.

Treasure Hunter

Venture Round in 2015
Treasure Hunter Co., Ltd. is a media content and marketing solutions provider based in Seoul, South Korea. Founded in 2015, the company specializes in the creation and optimization of media content, particularly in the Asian mobile video market. It offers a range of services including incubating systems for media creators that encompass basic education, studio support, and channel optimization. Additionally, Treasure Hunter provides brand analysis and strategy services to enhance content creation and YouTube channel management. The company also operates an educational institute that covers various subjects such as image planning, photography, copyright, and legal education. By focusing on innovative marketing solutions and community engagement, Treasure Hunter aims to deliver enjoyable content and support the growth of media creators and brands in the digital landscape.

AptaBio Therapeutics

Series A in 2015
AptaBio Therapeutics Inc. is a pharmaceutical biotechnology company based in Yongin-Si, South Korea, focused on discovering and developing innovative treatments, particularly selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company offers a range of transfection reagents, including Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX, designed to facilitate the introduction of DNA or RNA into eukaryotic cells. AptaBio's product pipeline includes several candidates, such as PX-115 for diabetic nephropathy, APX-1004 for diabetic retinopathy, and APX-311 intended for the treatment of non-alcoholic steatohepatitis (NASH). Founded in 2009, AptaBio Therapeutics aims to address significant medical needs through its innovative drug development efforts.

C-TRI

Venture Round in 2014
C-TRI is involved in the manufacturing and advancement of pharmaceutical products. C-Tri Co., Ltd., based in Namyangju, South Korea, specializes in the production and development of pharmaceutical products. They offer a wide range of products, including peptides, antiviral drugs, ionic liquids, and more. Additionally, C-Tri Co., Ltd. provides OTC and ETC contract services. The company was established in 1998.

SeeOn

Venture Round in 2012
SeeOn (씨온) is a Korean location-based social network service that allows users to contact other users and share experiences with one another. Established in 2012, SeeOn was awarded the social networking app of the year in 2012 in the LBS smart app awards.

SUNDAYTOZ

Venture Round in 2010
SundayToz Corp. is a South Korean company specializing in the development of casual social games. Founded in 2009 and headquartered in Seongnam, Gyeonggi-do, the company has created games for a variety of platforms, including Kakao Talk, Apple's App Store, Google Play, Facebook, and Naver. SundayToz gained recognition for its innovative content, receiving the Republic of Korea Presidential Award in December 2012 for next-generation-targeted content. The company launched its first application, Cyworld, in December 2009, marking the beginning of its contributions to the gaming industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.